Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
Sales | 138 | 222 | 175 | 524 | 768 |
Gross Profit | 138 | 222 | 175 | 524 | 768 |
Operating Expenses | 14,781 | 17,282 | 14,163 | 16,587 | 15,763 |
Operating Income | -14,643 | -17,060 | -13,988 | -16,063 | -14,995 |
Other Income | 249 | 184 | 160 | 98 | 85 |
Pre-tax Income | -14,394 | -16,876 | -13,828 | -15,965 | -14,910 |
Income Tax | N/A | N/A | N/A | -5,275 | -51 |
Net Income Continuous | -14,394 | -16,876 | -13,828 | -10,690 | -14,859 |
Net Income | $-14,394 | $-16,876 | $-13,828 | $-10,690 | $-14,859 |
EPS Basic Total Ops | -0.66 | -0.78 | -0.65 | -0.58 | -0.81 |
EPS Basic Continuous Ops | -0.66 | -0.78 | -0.65 | -0.58 | -0.81 |
EPS Diluted Total Ops | -0.66 | -0.78 | -0.65 | -0.58 | -0.81 |
EPS Diluted Continuous Ops | -0.66 | -0.78 | -0.65 | -0.58 | -0.81 |
EBITDA(a) | $-15,148 | $-16,720 | $-13,593 | $-15,909 | $-14,604 |